Accelerating Regenerative Medicine
Empowering Cell & Gene Therapy with AI
with AI
CytoHub is revolutionizing regenerative medicine with first-in-class, uniquely engineered, and highly differentiated iPSC-derived cardiac therapeutics designed to restore heart function and transform the lives of patients battling heart failure.
The CytoHub Platform Quadrant
The CytoHub Platform Quadrant
1. CardioVive™, 2. HeartReady™, 3. CytoScale™, and 4. BioEngineAI™ — these four pillars collectively define CytoHub’s approach to pioneering regenerative therapies, with the ultimate goal of transforming the lives of heart failure patients worldwide.
Recent News
Richard J. Anderson, Ph.D., joins CytoHub as VP, Tech Operations, brings 25+ years of clinical development and MSAT experience.
LA JOLLA, Calif.–(BUSINESS WIRE)–CytoHub, Inc., a pioneering developer of intelligent technologies for cell therapy and regenerative medicine, today announced the strategic addition of three top industry experts to its team.
LA JOLLA, Calif.–(BUSINESS WIRE)–CytoHub, Inc., a pioneering developer of intelligent technologies for cell therapy and regenerative medicine, today announced the strategic addition of three top industry experts to its team.
LA JOLLA, Calif.–(BUSINESS WIRE)–CytoHub, Inc., a pioneering developer of intelligent technologies for cell therapy and regenerative medicine, today announced the strategic addition of three top industry experts to its team.
LA JOLLA, Calif.–(BUSINESS WIRE)–CytoHub, Inc., a pioneering developer of intelligent technologies for cell therapy and regenerative medicine, today announced the strategic addition of three top industry experts to its team.
Our innovations at the intersection of stem cell biology and advanced engineering set us apart. By leveraging iPSC-derived cardiomyocytes, we’ve developed proprietary methods to improve cell maturation, scalability, and therapeutic outcomes. At the core of CytoHub’s platform are four key assets:
HeartReady™
Cryopreserved, off-the-shelf iPSC-derived cardiomyocytes as therapeutic candidate
CardioVive™
Human mini-heart platform for therapeutic screening and drug discovery
CytoScale™
Scale-up solutions powered by AI and world-class expertise
BioEngineAI™
An AI-driven platform enhancing cellular therapy and drug development
We partner & adopt the best-in-class models & technology
